Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended			3 Months Ended		9 Months Ended
	Nov. 08, 2022	Sep. 30, 2023	Nov. 30, 2022	Apr. 30, 2020	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Policies
Revenues					$ 268,306	$ 210,637	$ 771,466	$ 602,970
Net Income (Loss)					(109,030)	(121,480)	(356,770)	(405,226)
Accumulated deficit		$ 2,299,405			2,299,405		2,299,405		$ 1,942,635
Cash, cash equivalents and restricted cash		668,710			668,710	57,128	668,710	57,128	466,091	$ 84,614
Marketable securities		267,847			267,847		267,847		432,301
Short-term Credit Line, outstanding balance		80,435			80,435		80,435		$ 80,350
Borrowings under credit facility	$ 30,000						80,000
Remaining borrowing capacity		$ 20,000	$ 100,000		$ 20,000		$ 20,000
Common stock, shares issued		118,990,000	13,144,500		118,990,000		118,990,000		111,255,000
Stock issued (in dollars per share)		$ 55	$ 35		$ 55		$ 55
Payment of offering expenses		$ 400	$ 500
Proceeds from issuance of common stock		235,800	$ 433,200
Convertible Notes
Policies
Outstanding principal balance		$ 287,500		$ 287,500	$ 287,500		$ 287,500
Per annum interest rate (as a percent)				2.25%			2.25%
Net proceeds				$ 278,300
Equity offering
Policies
Common stock, shares issued		4,550,000			4,550,000		4,550,000
Licensing and other
Policies
Revenues					$ 3,088	10,806	$ 10,195	18,555
Cost of revenues					349	1,076	1,060	2,102
Product
Policies
Revenues					265,218	199,831	761,271	584,415
Cost of revenues					$ 146,962	$ 115,436	$ 437,524	$ 326,862